Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA3 | P07451 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8207425 | 0.77 | ALDH1A1 (0.50) | ALDH1A1TSHRDNM1TDP1CA12 | |
| SCHEMBL8928256 | 0.77 | ALDH1A1 (0.50) | ALDH1A1TSHRDNM1TDP1CA12 | |
| SCHEMBL3276577 | 0.76 | ALDH1A1 (0.43) | ALDH1A1TSHRDNM1TDP1CA12 | |
| Hydrochloric Acid SCHEMBL28914158 | 0.74 | ALDH1A1 (0.47) | ALDH1A1TSHRDNM1TDP1CA12 | |
| SCHEMBL12677791 | 0.72 | ALDH1A1 (0.45) | ALDH1A1TSHRDNM1TDP1CA12 | |
| SCHEMBL21741888 | 0.72 | ALDH1A1 (0.45) | ALDH1A1TSHRDNM1TDP1CA12 | |
| SCHEMBL19861866 | 0.72 | ALDH1A1 (0.45) | ALDH1A1TSHRDNM1TDP1CA12 | |
| SCHEMBL3777474 | 0.72 | ALDH1A1 (0.45) | ALDH1A1TSHRDNM1TDP1CA12 | |
| SCHEMBL3770900 | 0.72 | ALDH1A1 (0.45) | ALDH1A1TSHRDNM1TDP1CA12 | |
| SCHEMBL9703967 | 0.72 | ALDH1A1 (0.45) | ALDH1A1TSHRDNM1TDP1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10392449-B2 | Polymerization initiator, modified conjugated diene-based polymer, and methods for preparing them | LG CHEM, LTD. (KR) | 2019-08-27 | — | — | US | disclosed |
| US-20180112015-A1 | POLYMERIZATION INITIATOR, MODIFIED CONJUGATED DIENE-BASED POLYMER, AND METHODS FOR PREPARING THEM | LG CHEM, LTD. (KR) | 2018-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180112015-A1 | POLYMERIZATION INITIATOR, MODIFIED CONJUGATED DIENE-BASED POLYMER, AND METHODS FOR PREPARING THEM | RIF1, RAD51, TRRAP | ALDH1A1 517/4885TSHR 3880/4885DNM1 1630/4885 |
| US-10392449-B2 | Polymerization initiator, modified conjugated diene-based polymer, and methods for preparing them | RIF1, RAD51, TRRAP | ALDH1A1 517/4885TSHR 3880/4885DNM1 1630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.